17 September 2009
Physicians report new information at the Society for Vascular Surgery's annual meeting
18 March 2009
Multi-center, multi-year, worldwide data presented adds to the growing body of evidence for ePTFE Heparin Vascular Graft
08 October 2008
Gore continues commitment to clinical research with symposia, ongoing clinical studies and emerging technologies
22 July 2008
Interim and pivotal data presented at Society of Vascular Surgery’s Annual Meeting
24 March 2008
Post-market study to compare performance of GORE PROPATEN Vascular Graft todisadvantaged autologous vein graft in below-knee peripheral arterial disease bypasses.
11 December 2007
W. L. Gore & Associates (Gore) announced that interim results from multi-year, multi-center studies using the GORE PROPATEN Vascular Graft were presented recently at the 34th Annual VEITHsymposium™ in New York.
29 November 2006
W. L. Gore & Associates today announced that Georgetown University Medical Center in Washington, D.C. was the site of the first U.S. implant of the GORE PROPATEN Vascular Graft since its FDA clearance earlier this month.
16 November 2006
Gore transcends mechanical solutions for lower-limb surgery with a ePTFE-heparin combination
05 October 2005
W. L. Gore & Associates, Inc. (Gore) announced today that it has acquired Carmeda AB, a Sweden-based manufacturer of the most clinically proven, hemocompatible surface coating for medical devices.